FIELD: medicine; pharmacology.
SUBSTANCE: invention can be used as new agent for correction of carbohydrate metabolic disorders to prevent and treat insular diabetes II type. Agent represents ecdysteroids-containing substance extracted from aerial saw-wort Serratula coronata L. (Asteraceae) representing mixed 20-hydroxyecdysone in amount not less than 75% and 25S-inocosterone in amount not less than 10%.
EFFECT: sugar-reducing and hypolipidemic activity of agent.
3 ex, 3 tbl, 12 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIDIABETIC, HYPOLIPIDEMIC, HYPOGLYCEMIC AND CHOLESTEROL LOWERING ACTION, WAY OF ITS RECEPTION AND WAYS OF TREATMENT OF SPECIFIED DISEASES | 2007 |
|
RU2361581C2 |
| HYPOLIPIDEMIC AND ANTIISHEMIC AGENT "SERPYSTEN" | 2007 |
|
RU2337701C1 |
| PHARMACEUTICAL COMPOSITION BASED ON GREEN COFFEE BERRY EXTRACT, METHOD FOR MAKING AND APPLYING | 2008 |
|
RU2378003C1 |
| CLATHRATE COMPLEX OF ARABINOGALACTAN OR ARABIC GUM WITH 20-HYDROXYECDYSONES, METHOD FOR PRODUCING IT (VERSIONS), PHARMACEUTICAL COMPOSITION AND MEDICINAL PRODUCT | 2013 |
|
RU2572334C2 |
| MEANS FOR TREATING DIABETES | 2000 |
|
RU2165767C1 |
| MEDICINAL PRODUCT FOR DIABETES TREATMENT | 2006 |
|
RU2329813C2 |
| AGENT POSSESSING ANTIDIABETIC ACTIVITY | 2006 |
|
RU2313361C1 |
| ANTIAGGREGATORY AND STRESS LIMITING AGENT | 2008 |
|
RU2375071C1 |
| MEDICATION AND METHOD OF COMPLEX THERAPY OF PATIENTS WITH DIABETES MELLITUS | 2012 |
|
RU2548731C2 |
| NOVEL CHELATE COMPOUND OF OXOVANADIUM (IV) WITH ISONICOTINIC ACID HYDRAZIDE SHOWING ANTIDIABETIC ACTION AND ELICITING ANTIMYCOBACTERIAL ACTIVITY | 1999 |
|
RU2190618C2 |
